nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroxyaluminium—VDAC3—nipple—breast cancer	0.019	0.0479	CbGeAlD
Dihydroxyaluminium—VDAC1—nipple—breast cancer	0.018	0.0456	CbGeAlD
Dihydroxyaluminium—VDAC2—epithelium—breast cancer	0.0153	0.0387	CbGeAlD
Dihydroxyaluminium—VDAC2—skin of body—breast cancer	0.0146	0.0368	CbGeAlD
Dihydroxyaluminium—VDAC2—uterus—breast cancer	0.0127	0.032	CbGeAlD
Dihydroxyaluminium—VDAC2—adipose tissue—breast cancer	0.0124	0.0313	CbGeAlD
Dihydroxyaluminium—VDAC1—epithelium—breast cancer	0.0121	0.0307	CbGeAlD
Dihydroxyaluminium—VDAC3—skin of body—breast cancer	0.0121	0.0307	CbGeAlD
Dihydroxyaluminium—VDAC1—skin of body—breast cancer	0.0115	0.0292	CbGeAlD
Dihydroxyaluminium—VDAC3—endometrium—breast cancer	0.0114	0.0289	CbGeAlD
Dihydroxyaluminium—VDAC2—female reproductive system—breast cancer	0.0114	0.0288	CbGeAlD
Dihydroxyaluminium—VDAC2—adrenal gland—breast cancer	0.0111	0.0281	CbGeAlD
Dihydroxyaluminium—VDAC1—endometrium—breast cancer	0.0109	0.0275	CbGeAlD
Dihydroxyaluminium—VDAC3—uterus—breast cancer	0.0105	0.0267	CbGeAlD
Dihydroxyaluminium—VDAC3—pituitary gland—breast cancer	0.0104	0.0262	CbGeAlD
Dihydroxyaluminium—VDAC2—female gonad—breast cancer	0.0104	0.0262	CbGeAlD
Dihydroxyaluminium—VDAC3—adipose tissue—breast cancer	0.0103	0.0261	CbGeAlD
Dihydroxyaluminium—VDAC1—uterus—breast cancer	0.01	0.0254	CbGeAlD
Dihydroxyaluminium—VDAC1—pituitary gland—breast cancer	0.00985	0.0249	CbGeAlD
Dihydroxyaluminium—VDAC1—adipose tissue—breast cancer	0.00981	0.0248	CbGeAlD
Dihydroxyaluminium—VDAC2—endocrine gland—breast cancer	0.00963	0.0243	CbGeAlD
Dihydroxyaluminium—VDAC3—female reproductive system—breast cancer	0.00948	0.024	CbGeAlD
Dihydroxyaluminium—TNNC1—endometrium—breast cancer	0.00933	0.0236	CbGeAlD
Dihydroxyaluminium—VDAC3—adrenal gland—breast cancer	0.00925	0.0234	CbGeAlD
Dihydroxyaluminium—VDAC1—female reproductive system—breast cancer	0.00902	0.0228	CbGeAlD
Dihydroxyaluminium—VDAC3—bone marrow—breast cancer	0.00895	0.0226	CbGeAlD
Dihydroxyaluminium—VDAC1—adrenal gland—breast cancer	0.0088	0.0222	CbGeAlD
Dihydroxyaluminium—VDAC3—female gonad—breast cancer	0.00863	0.0218	CbGeAlD
Dihydroxyaluminium—VDAC1—bone marrow—breast cancer	0.00851	0.0215	CbGeAlD
Dihydroxyaluminium—TNNC1—pituitary gland—breast cancer	0.00844	0.0213	CbGeAlD
Dihydroxyaluminium—TNNC1—adipose tissue—breast cancer	0.00841	0.0213	CbGeAlD
Dihydroxyaluminium—VDAC1—female gonad—breast cancer	0.0082	0.0207	CbGeAlD
Dihydroxyaluminium—VDAC3—endocrine gland—breast cancer	0.00802	0.0203	CbGeAlD
Dihydroxyaluminium—VDAC1—endocrine gland—breast cancer	0.00763	0.0193	CbGeAlD
Dihydroxyaluminium—TNNC1—adrenal gland—breast cancer	0.00754	0.0191	CbGeAlD
Dihydroxyaluminium—VDAC2—lymph node—breast cancer	0.00666	0.0168	CbGeAlD
Dihydroxyaluminium—VDAC3—lymph node—breast cancer	0.00555	0.014	CbGeAlD
Dihydroxyaluminium—VDAC1—lymph node—breast cancer	0.00527	0.0133	CbGeAlD
Dihydroxyaluminium—TNNC1—lymph node—breast cancer	0.00452	0.0114	CbGeAlD
Dihydroxyaluminium—Tachycardia—Goserelin—breast cancer	0.000925	0.00153	CcSEcCtD
Dihydroxyaluminium—Vomiting—Anastrozole—breast cancer	0.000922	0.00152	CcSEcCtD
Dihydroxyaluminium—Vomiting—Letrozole—breast cancer	0.000922	0.00152	CcSEcCtD
Dihydroxyaluminium—Dehydration—Docetaxel—breast cancer	0.000915	0.00151	CcSEcCtD
Dihydroxyaluminium—Nausea—Ixabepilone—breast cancer	0.000914	0.00151	CcSEcCtD
Dihydroxyaluminium—Dizziness—Raloxifene—breast cancer	0.00091	0.00151	CcSEcCtD
Dihydroxyaluminium—Hypotension—Melphalan—breast cancer	0.000908	0.0015	CcSEcCtD
Dihydroxyaluminium—Urinary retention—Capecitabine—breast cancer	0.000906	0.0015	CcSEcCtD
Dihydroxyaluminium—Coma—Methotrexate—breast cancer	0.000893	0.00148	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Epirubicin—breast cancer	0.000888	0.00147	CcSEcCtD
Dihydroxyaluminium—Dehydration—Capecitabine—breast cancer	0.000886	0.00147	CcSEcCtD
Dihydroxyaluminium—Hypotension—Goserelin—breast cancer	0.000885	0.00146	CcSEcCtD
Dihydroxyaluminium—Urticaria—Chlorambucil—breast cancer	0.000885	0.00146	CcSEcCtD
Dihydroxyaluminium—Chills—Mitoxantrone—breast cancer	0.000884	0.00146	CcSEcCtD
Dihydroxyaluminium—Chills—Irinotecan—breast cancer	0.000884	0.00146	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Chlorambucil—breast cancer	0.000881	0.00146	CcSEcCtD
Dihydroxyaluminium—Vomiting—Raloxifene—breast cancer	0.000875	0.00145	CcSEcCtD
Dihydroxyaluminium—Vomiting—Idarubicin—breast cancer	0.000875	0.00145	CcSEcCtD
Dihydroxyaluminium—Pain—Vinblastine—breast cancer	0.000873	0.00144	CcSEcCtD
Dihydroxyaluminium—Nausea—Letrozole—breast cancer	0.000861	0.00142	CcSEcCtD
Dihydroxyaluminium—Nausea—Anastrozole—breast cancer	0.000861	0.00142	CcSEcCtD
Dihydroxyaluminium—Chills—Gemcitabine—breast cancer	0.000861	0.00142	CcSEcCtD
Dihydroxyaluminium—Convulsion—Thiotepa—breast cancer	0.00086	0.00142	CcSEcCtD
Dihydroxyaluminium—Pain—Tamoxifen—breast cancer	0.000848	0.0014	CcSEcCtD
Dihydroxyaluminium—Infection—Vinorelbine—breast cancer	0.000843	0.00139	CcSEcCtD
Dihydroxyaluminium—Coma—Epirubicin—breast cancer	0.000836	0.00138	CcSEcCtD
Dihydroxyaluminium—Pain—Melphalan—breast cancer	0.000831	0.00137	CcSEcCtD
Dihydroxyaluminium—Back pain—Irinotecan—breast cancer	0.000829	0.00137	CcSEcCtD
Dihydroxyaluminium—Back pain—Mitoxantrone—breast cancer	0.000829	0.00137	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Docetaxel—breast cancer	0.000829	0.00137	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Vinorelbine—breast cancer	0.000828	0.00137	CcSEcCtD
Dihydroxyaluminium—Salivary hypersecretion—Doxorubicin—breast cancer	0.000822	0.00136	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Chlorambucil—breast cancer	0.000821	0.00136	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Methotrexate—breast cancer	0.00082	0.00136	CcSEcCtD
Dihydroxyaluminium—Nausea—Idarubicin—breast cancer	0.000817	0.00135	CcSEcCtD
Dihydroxyaluminium—Nausea—Raloxifene—breast cancer	0.000817	0.00135	CcSEcCtD
Dihydroxyaluminium—Pain—Goserelin—breast cancer	0.00081	0.00134	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Mitoxantrone—breast cancer	0.000808	0.00134	CcSEcCtD
Dihydroxyaluminium—Back pain—Gemcitabine—breast cancer	0.000808	0.00134	CcSEcCtD
Dihydroxyaluminium—Polyuria—Methotrexate—breast cancer	0.000808	0.00134	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Paclitaxel—breast cancer	0.000805	0.00133	CcSEcCtD
Dihydroxyaluminium—Infection—Thiotepa—breast cancer	0.000805	0.00133	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Capecitabine—breast cancer	0.000802	0.00133	CcSEcCtD
Dihydroxyaluminium—Hypotension—Vinorelbine—breast cancer	0.000793	0.00131	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Thiotepa—breast cancer	0.000791	0.00131	CcSEcCtD
Dihydroxyaluminium—Urticaria—Tamoxifen—breast cancer	0.000788	0.0013	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Paclitaxel—breast cancer	0.000774	0.00128	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Fluorouracil—breast cancer	0.000774	0.00128	CcSEcCtD
Dihydroxyaluminium—Coma—Doxorubicin—breast cancer	0.000773	0.00128	CcSEcCtD
Dihydroxyaluminium—Urticaria—Melphalan—breast cancer	0.000772	0.00128	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Epirubicin—breast cancer	0.000771	0.00127	CcSEcCtD
Dihydroxyaluminium—Vertigo—Irinotecan—breast cancer	0.00077	0.00127	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Epirubicin—breast cancer	0.000767	0.00127	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Chlorambucil—breast cancer	0.000762	0.00126	CcSEcCtD
Dihydroxyaluminium—Urticaria—Goserelin—breast cancer	0.000753	0.00125	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Vinblastine—breast cancer	0.000752	0.00124	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Goserelin—breast cancer	0.000749	0.00124	CcSEcCtD
Dihydroxyaluminium—Visual disturbance—Methotrexate—breast cancer	0.000749	0.00124	CcSEcCtD
Dihydroxyaluminium—Convulsion—Mitoxantrone—breast cancer	0.000743	0.00123	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Tamoxifen—breast cancer	0.000731	0.00121	CcSEcCtD
Dihydroxyaluminium—Pain—Vinorelbine—breast cancer	0.000726	0.0012	CcSEcCtD
Dihydroxyaluminium—Chills—Paclitaxel—breast cancer	0.000721	0.00119	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Melphalan—breast cancer	0.000716	0.00118	CcSEcCtD
Dihydroxyaluminium—Phlebitis—Doxorubicin—breast cancer	0.000713	0.00118	CcSEcCtD
Dihydroxyaluminium—Convulsion—Fluorouracil—breast cancer	0.000712	0.00118	CcSEcCtD
Dihydroxyaluminium—Thrombophlebitis—Doxorubicin—breast cancer	0.00071	0.00117	CcSEcCtD
Dihydroxyaluminium—Vomiting—Chlorambucil—breast cancer	0.000708	0.00117	CcSEcCtD
Dihydroxyaluminium—Oedema—Mitoxantrone—breast cancer	0.0007	0.00116	CcSEcCtD
Dihydroxyaluminium—Oedema—Irinotecan—breast cancer	0.0007	0.00116	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Vinblastine—breast cancer	0.000699	0.00116	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Goserelin—breast cancer	0.000698	0.00115	CcSEcCtD
Dihydroxyaluminium—Infection—Mitoxantrone—breast cancer	0.000695	0.00115	CcSEcCtD
Dihydroxyaluminium—Infection—Irinotecan—breast cancer	0.000695	0.00115	CcSEcCtD
Dihydroxyaluminium—Pain—Thiotepa—breast cancer	0.000693	0.00115	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Mitoxantrone—breast cancer	0.000683	0.00113	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Docetaxel—breast cancer	0.000683	0.00113	CcSEcCtD
Dihydroxyaluminium—Oedema—Gemcitabine—breast cancer	0.000682	0.00113	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Tamoxifen—breast cancer	0.000679	0.00112	CcSEcCtD
Dihydroxyaluminium—Infection—Gemcitabine—breast cancer	0.000677	0.00112	CcSEcCtD
Dihydroxyaluminium—Back pain—Paclitaxel—breast cancer	0.000676	0.00112	CcSEcCtD
Dihydroxyaluminium—Dizziness—Vinblastine—breast cancer	0.000675	0.00112	CcSEcCtD
Dihydroxyaluminium—Urticaria—Vinorelbine—breast cancer	0.000674	0.00112	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Vinorelbine—breast cancer	0.000671	0.00111	CcSEcCtD
Dihydroxyaluminium—Oedema—Fluorouracil—breast cancer	0.00067	0.00111	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Epirubicin—breast cancer	0.000667	0.0011	CcSEcCtD
Dihydroxyaluminium—Infection—Fluorouracil—breast cancer	0.000666	0.0011	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Melphalan—breast cancer	0.000665	0.0011	CcSEcCtD
Dihydroxyaluminium—Nausea—Chlorambucil—breast cancer	0.000662	0.0011	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Capecitabine—breast cancer	0.000661	0.00109	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Paclitaxel—breast cancer	0.000659	0.00109	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Docetaxel—breast cancer	0.000656	0.00109	CcSEcCtD
Dihydroxyaluminium—Dizziness—Tamoxifen—breast cancer	0.000656	0.00109	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Fluorouracil—breast cancer	0.000654	0.00108	CcSEcCtD
Dihydroxyaluminium—Hypotension—Mitoxantrone—breast cancer	0.000654	0.00108	CcSEcCtD
Dihydroxyaluminium—Hypotension—Irinotecan—breast cancer	0.000654	0.00108	CcSEcCtD
Dihydroxyaluminium—Vomiting—Vinblastine—breast cancer	0.000649	0.00107	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Goserelin—breast cancer	0.000648	0.00107	CcSEcCtD
Dihydroxyaluminium—Urticaria—Thiotepa—breast cancer	0.000644	0.00107	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Thiotepa—breast cancer	0.000641	0.00106	CcSEcCtD
Dihydroxyaluminium—Hypotension—Gemcitabine—breast cancer	0.000637	0.00105	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Capecitabine—breast cancer	0.000635	0.00105	CcSEcCtD
Dihydroxyaluminium—Vomiting—Tamoxifen—breast cancer	0.000631	0.00104	CcSEcCtD
Dihydroxyaluminium—Vertigo—Paclitaxel—breast cancer	0.000628	0.00104	CcSEcCtD
Dihydroxyaluminium—Dizziness—Goserelin—breast cancer	0.000627	0.00104	CcSEcCtD
Dihydroxyaluminium—Hypotension—Fluorouracil—breast cancer	0.000626	0.00104	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Vinorelbine—breast cancer	0.000625	0.00103	CcSEcCtD
Dihydroxyaluminium—Vomiting—Melphalan—breast cancer	0.000618	0.00102	CcSEcCtD
Dihydroxyaluminium—Dehydration—Epirubicin—breast cancer	0.000617	0.00102	CcSEcCtD
Dihydroxyaluminium—Hyponatraemia—Doxorubicin—breast cancer	0.000617	0.00102	CcSEcCtD
Dihydroxyaluminium—Chills—Docetaxel—breast cancer	0.000611	0.00101	CcSEcCtD
Dihydroxyaluminium—Nausea—Vinblastine—breast cancer	0.000607	0.001	CcSEcCtD
Dihydroxyaluminium—Convulsion—Paclitaxel—breast cancer	0.000606	0.001	CcSEcCtD
Dihydroxyaluminium—Vomiting—Goserelin—breast cancer	0.000602	0.000997	CcSEcCtD
Dihydroxyaluminium—Pain—Irinotecan—breast cancer	0.000598	0.00099	CcSEcCtD
Dihydroxyaluminium—Pain—Mitoxantrone—breast cancer	0.000598	0.00099	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Thiotepa—breast cancer	0.000597	0.000988	CcSEcCtD
Dihydroxyaluminium—Chills—Capecitabine—breast cancer	0.000592	0.000979	CcSEcCtD
Dihydroxyaluminium—Nausea—Tamoxifen—breast cancer	0.000589	0.000975	CcSEcCtD
Dihydroxyaluminium—Pain—Gemcitabine—breast cancer	0.000583	0.000964	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Vinorelbine—breast cancer	0.000581	0.000961	CcSEcCtD
Dihydroxyaluminium—Nausea—Melphalan—breast cancer	0.000577	0.000955	CcSEcCtD
Dihydroxyaluminium—Back pain—Docetaxel—breast cancer	0.000573	0.000949	CcSEcCtD
Dihydroxyaluminium—Pain—Fluorouracil—breast cancer	0.000573	0.000948	CcSEcCtD
Dihydroxyaluminium—Dehydration—Doxorubicin—breast cancer	0.000571	0.000945	CcSEcCtD
Dihydroxyaluminium—Oedema—Paclitaxel—breast cancer	0.000571	0.000944	CcSEcCtD
Dihydroxyaluminium—Infection—Paclitaxel—breast cancer	0.000567	0.000938	CcSEcCtD
Dihydroxyaluminium—Nausea—Goserelin—breast cancer	0.000563	0.000931	CcSEcCtD
Dihydroxyaluminium—Dizziness—Vinorelbine—breast cancer	0.000561	0.000928	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Epirubicin—breast cancer	0.000559	0.000925	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Paclitaxel—breast cancer	0.000557	0.000922	CcSEcCtD
Dihydroxyaluminium—Urticaria—Mitoxantrone—breast cancer	0.000556	0.00092	CcSEcCtD
Dihydroxyaluminium—Back pain—Capecitabine—breast cancer	0.000555	0.000918	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Thiotepa—breast cancer	0.000554	0.000917	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Irinotecan—breast cancer	0.000553	0.000915	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Mitoxantrone—breast cancer	0.000553	0.000915	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Capecitabine—breast cancer	0.000541	0.000895	CcSEcCtD
Dihydroxyaluminium—Vomiting—Vinorelbine—breast cancer	0.00054	0.000893	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Gemcitabine—breast cancer	0.000539	0.000892	CcSEcCtD
Dihydroxyaluminium—Dizziness—Thiotepa—breast cancer	0.000536	0.000887	CcSEcCtD
Dihydroxyaluminium—Hypotension—Paclitaxel—breast cancer	0.000533	0.000882	CcSEcCtD
Dihydroxyaluminium—Urticaria—Fluorouracil—breast cancer	0.000532	0.000881	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Fluorouracil—breast cancer	0.00053	0.000877	CcSEcCtD
Dihydroxyaluminium—Angina pectoris—Doxorubicin—breast cancer	0.000517	0.000856	CcSEcCtD
Dihydroxyaluminium—Vertigo—Capecitabine—breast cancer	0.000516	0.000853	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Irinotecan—breast cancer	0.000516	0.000853	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Mitoxantrone—breast cancer	0.000516	0.000853	CcSEcCtD
Dihydroxyaluminium—Vomiting—Thiotepa—breast cancer	0.000515	0.000852	CcSEcCtD
Dihydroxyaluminium—Convulsion—Docetaxel—breast cancer	0.000514	0.00085	CcSEcCtD
Dihydroxyaluminium—Nausea—Vinorelbine—breast cancer	0.000504	0.000834	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Fluorouracil—breast cancer	0.000494	0.000817	CcSEcCtD
Dihydroxyaluminium—Pain—Paclitaxel—breast cancer	0.000488	0.000808	CcSEcCtD
Dihydroxyaluminium—Oedema—Docetaxel—breast cancer	0.000484	0.0008	CcSEcCtD
Dihydroxyaluminium—Nausea—Thiotepa—breast cancer	0.000481	0.000796	CcSEcCtD
Dihydroxyaluminium—Infection—Docetaxel—breast cancer	0.000481	0.000795	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Irinotecan—breast cancer	0.000479	0.000792	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Mitoxantrone—breast cancer	0.000479	0.000792	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Methotrexate—breast cancer	0.000473	0.000782	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Docetaxel—breast cancer	0.000472	0.000781	CcSEcCtD
Dihydroxyaluminium—Oedema—Capecitabine—breast cancer	0.000468	0.000775	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Gemcitabine—breast cancer	0.000466	0.000772	CcSEcCtD
Dihydroxyaluminium—Infection—Capecitabine—breast cancer	0.000465	0.00077	CcSEcCtD
Dihydroxyaluminium—Dizziness—Irinotecan—breast cancer	0.000463	0.000766	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Epirubicin—breast cancer	0.00046	0.000762	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Fluorouracil—breast cancer	0.000459	0.000759	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Capecitabine—breast cancer	0.000457	0.000756	CcSEcCtD
Dihydroxyaluminium—Urticaria—Paclitaxel—breast cancer	0.000453	0.00075	CcSEcCtD
Dihydroxyaluminium—Hypotension—Docetaxel—breast cancer	0.000452	0.000748	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Paclitaxel—breast cancer	0.000451	0.000746	CcSEcCtD
Dihydroxyaluminium—Vomiting—Irinotecan—breast cancer	0.000445	0.000736	CcSEcCtD
Dihydroxyaluminium—Vomiting—Mitoxantrone—breast cancer	0.000445	0.000736	CcSEcCtD
Dihydroxyaluminium—Dizziness—Fluorouracil—breast cancer	0.000443	0.000733	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Epirubicin—breast cancer	0.000443	0.000732	CcSEcCtD
Dihydroxyaluminium—Chills—Methotrexate—breast cancer	0.00044	0.000729	CcSEcCtD
Dihydroxyaluminium—Hypotension—Capecitabine—breast cancer	0.000438	0.000724	CcSEcCtD
Dihydroxyaluminium—Vomiting—Gemcitabine—breast cancer	0.000433	0.000717	CcSEcCtD
Dihydroxyaluminium—Vomiting—Fluorouracil—breast cancer	0.000426	0.000705	CcSEcCtD
Dihydroxyaluminium—Rhinitis—Doxorubicin—breast cancer	0.000426	0.000705	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Paclitaxel—breast cancer	0.000421	0.000696	CcSEcCtD
Dihydroxyaluminium—Nausea—Irinotecan—breast cancer	0.000416	0.000688	CcSEcCtD
Dihydroxyaluminium—Nausea—Mitoxantrone—breast cancer	0.000416	0.000688	CcSEcCtD
Dihydroxyaluminium—Pain—Docetaxel—breast cancer	0.000414	0.000684	CcSEcCtD
Dihydroxyaluminium—Back pain—Methotrexate—breast cancer	0.000413	0.000684	CcSEcCtD
Dihydroxyaluminium—Chills—Epirubicin—breast cancer	0.000412	0.000682	CcSEcCtD
Dihydroxyaluminium—Visual impairment—Doxorubicin—breast cancer	0.00041	0.000678	CcSEcCtD
Dihydroxyaluminium—Nausea—Gemcitabine—breast cancer	0.000405	0.00067	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Methotrexate—breast cancer	0.000403	0.000666	CcSEcCtD
Dihydroxyaluminium—Pain—Capecitabine—breast cancer	0.000401	0.000663	CcSEcCtD
Dihydroxyaluminium—Nausea—Fluorouracil—breast cancer	0.000398	0.000659	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Paclitaxel—breast cancer	0.000391	0.000646	CcSEcCtD
Dihydroxyaluminium—Back pain—Epirubicin—breast cancer	0.000387	0.00064	CcSEcCtD
Dihydroxyaluminium—Vertigo—Methotrexate—breast cancer	0.000384	0.000635	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Docetaxel—breast cancer	0.000382	0.000633	CcSEcCtD
Dihydroxyaluminium—Chills—Doxorubicin—breast cancer	0.000381	0.000631	CcSEcCtD
Dihydroxyaluminium—Dizziness—Paclitaxel—breast cancer	0.000377	0.000624	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Epirubicin—breast cancer	0.000377	0.000623	CcSEcCtD
Dihydroxyaluminium—Urticaria—Capecitabine—breast cancer	0.000372	0.000616	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Capecitabine—breast cancer	0.00037	0.000613	CcSEcCtD
Dihydroxyaluminium—Convulsion—Methotrexate—breast cancer	0.00037	0.000612	CcSEcCtD
Dihydroxyaluminium—Vomiting—Paclitaxel—breast cancer	0.000363	0.0006	CcSEcCtD
Dihydroxyaluminium—Vertigo—Epirubicin—breast cancer	0.000359	0.000594	CcSEcCtD
Dihydroxyaluminium—Back pain—Doxorubicin—breast cancer	0.000358	0.000592	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Docetaxel—breast cancer	0.000356	0.00059	CcSEcCtD
Dihydroxyaluminium—Vision blurred—Doxorubicin—breast cancer	0.000349	0.000577	CcSEcCtD
Dihydroxyaluminium—Convulsion—Epirubicin—breast cancer	0.000346	0.000573	CcSEcCtD
Dihydroxyaluminium—Infection—Methotrexate—breast cancer	0.000346	0.000573	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Capecitabine—breast cancer	0.000345	0.000571	CcSEcCtD
Dihydroxyaluminium—Nausea—Paclitaxel—breast cancer	0.000339	0.000561	CcSEcCtD
Dihydroxyaluminium—Vertigo—Doxorubicin—breast cancer	0.000332	0.00055	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Docetaxel—breast cancer	0.000331	0.000548	CcSEcCtD
Dihydroxyaluminium—Oedema—Epirubicin—breast cancer	0.000326	0.00054	CcSEcCtD
Dihydroxyaluminium—Hypotension—Methotrexate—breast cancer	0.000326	0.000539	CcSEcCtD
Dihydroxyaluminium—Infection—Epirubicin—breast cancer	0.000324	0.000536	CcSEcCtD
Dihydroxyaluminium—Convulsion—Doxorubicin—breast cancer	0.000321	0.00053	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Capecitabine—breast cancer	0.00032	0.00053	CcSEcCtD
Dihydroxyaluminium—Dizziness—Docetaxel—breast cancer	0.00032	0.000529	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Epirubicin—breast cancer	0.000318	0.000527	CcSEcCtD
Dihydroxyaluminium—Dizziness—Capecitabine—breast cancer	0.00031	0.000512	CcSEcCtD
Dihydroxyaluminium—Vomiting—Docetaxel—breast cancer	0.000308	0.000509	CcSEcCtD
Dihydroxyaluminium—Hypotension—Epirubicin—breast cancer	0.000305	0.000504	CcSEcCtD
Dihydroxyaluminium—Oedema—Doxorubicin—breast cancer	0.000302	0.0005	CcSEcCtD
Dihydroxyaluminium—Infection—Doxorubicin—breast cancer	0.0003	0.000496	CcSEcCtD
Dihydroxyaluminium—Pain—Methotrexate—breast cancer	0.000298	0.000493	CcSEcCtD
Dihydroxyaluminium—Vomiting—Capecitabine—breast cancer	0.000298	0.000493	CcSEcCtD
Dihydroxyaluminium—Tachycardia—Doxorubicin—breast cancer	0.000295	0.000488	CcSEcCtD
Dihydroxyaluminium—Nausea—Docetaxel—breast cancer	0.000287	0.000475	CcSEcCtD
Dihydroxyaluminium—Hypotension—Doxorubicin—breast cancer	0.000282	0.000467	CcSEcCtD
Dihydroxyaluminium—Pain—Epirubicin—breast cancer	0.000279	0.000462	CcSEcCtD
Dihydroxyaluminium—Nausea—Capecitabine—breast cancer	0.000278	0.00046	CcSEcCtD
Dihydroxyaluminium—Urticaria—Methotrexate—breast cancer	0.000277	0.000458	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Methotrexate—breast cancer	0.000276	0.000456	CcSEcCtD
Dihydroxyaluminium—Urticaria—Epirubicin—breast cancer	0.000259	0.000429	CcSEcCtD
Dihydroxyaluminium—Pain—Doxorubicin—breast cancer	0.000258	0.000427	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Epirubicin—breast cancer	0.000258	0.000427	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Methotrexate—breast cancer	0.000257	0.000425	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Epirubicin—breast cancer	0.00024	0.000398	CcSEcCtD
Dihydroxyaluminium—Urticaria—Doxorubicin—breast cancer	0.00024	0.000397	CcSEcCtD
Dihydroxyaluminium—Body temperature increased—Doxorubicin—breast cancer	0.000239	0.000395	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Methotrexate—breast cancer	0.000239	0.000395	CcSEcCtD
Dihydroxyaluminium—Dizziness—Methotrexate—breast cancer	0.000231	0.000381	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Epirubicin—breast cancer	0.000223	0.000369	CcSEcCtD
Dihydroxyaluminium—Hypersensitivity—Doxorubicin—breast cancer	0.000222	0.000368	CcSEcCtD
Dihydroxyaluminium—Vomiting—Methotrexate—breast cancer	0.000222	0.000367	CcSEcCtD
Dihydroxyaluminium—Dizziness—Epirubicin—breast cancer	0.000216	0.000357	CcSEcCtD
Dihydroxyaluminium—Vomiting—Epirubicin—breast cancer	0.000207	0.000343	CcSEcCtD
Dihydroxyaluminium—Nausea—Methotrexate—breast cancer	0.000207	0.000343	CcSEcCtD
Dihydroxyaluminium—Diarrhoea—Doxorubicin—breast cancer	0.000207	0.000342	CcSEcCtD
Dihydroxyaluminium—Dizziness—Doxorubicin—breast cancer	0.0002	0.00033	CcSEcCtD
Dihydroxyaluminium—Nausea—Epirubicin—breast cancer	0.000194	0.000321	CcSEcCtD
Dihydroxyaluminium—Vomiting—Doxorubicin—breast cancer	0.000192	0.000318	CcSEcCtD
Dihydroxyaluminium—Nausea—Doxorubicin—breast cancer	0.000179	0.000297	CcSEcCtD
